Elanco Shares Are Trading Higher After the Company Received FDA Approval for Credelio Quattro Broad-spectrum Canine Oral Parasiticide in a Monthly Dose.
Elanco Shares Are Trading Higher After the Company Received FDA Approval for Credelio Quattro Broad-spectrum Canine Oral Parasiticide in a Monthly Dose.
艾科康股價上漲，因公司獲得了FDA批准，可每月使用Credelio Quattro廣譜犬用口服寄生蟲藥。
Elanco Shares Are Trading Higher After the Company Received FDA Approval for Credelio Quattro Broad-spectrum Canine Oral Parasiticide in a Monthly Dose.
在Elanco獲得美國食品藥品管理局批准每月劑量的Credelio Quattro廣譜犬用口服寄生蟲殺蟲劑後，該公司股價走高。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。